BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
Journal of Infection and Public Health2016Vol. 9(3), pp. 220–226
Citations Over TimeTop 1% of 2016 papers
Raymond Taylor, Pravin L. Kotian, Travis K. Warren, Rekha G. Panchal, Sina Bavari, Justin G. Julander, Sylvia Dobo, Angela M. Rose, Yahya El-Kattan, Brian R. Taubenheim, Y.S. Babu, William Sheridan
Related Papers
- → Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates(2019)60 cited
- → Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo(2019)34 cited
- → Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment(2019)14 cited
- → The crystal structure of the C-terminal domain of the Ebola virus nucleoprotein(2014)
- Comprehensive Profiling of Immune Responses in MARV Survivors Demonstrates Robust Th1-Skewing with Short-Lived Neutralizing Antibody Responses(2017)